These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10868822)

  • 1. Isotypes of anti-islet autoantibodies.
    Eisenbarth GS
    Diabetes Care; 2000 Feb; 23(2):151-2. PubMed ID: 10868822
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality.
    Hawa MI; Fava D; Medici F; Deng YJ; Notkins AL; De Mattia G; Leslie RD
    Diabetes Care; 2000 Feb; 23(2):228-33. PubMed ID: 10868836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract]   [Full Text] [Related]  

  • 4. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
    Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus.
    Lohmann T; Hawa M; Leslie RD; Lane R; Picard J; Londei M
    Lancet; 2000 Jul; 356(9223):31-5. PubMed ID: 10892762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoantibodies against GAD, GAD65 and IA-2].
    Tsujii S
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():395-400. PubMed ID: 12355780
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular manipulation of autoantibody testing in type 1 diabetes: two for one.
    Sacks DB; Lernmark A
    Clin Chem; 2001 May; 47(5):803-4. PubMed ID: 11325879
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies.
    Costa A; Conget I; Casamitjana R
    Diabetes Care; 2000 Jun; 23(6):874. PubMed ID: 10841023
    [No Abstract]   [Full Text] [Related]  

  • 9. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy.
    Tuomi T; Zimmet PZ; Rowley MJ; Serjeantson SW; Mackay IR
    Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590
    [No Abstract]   [Full Text] [Related]  

  • 10. Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes.
    Ronkainen MS; Hoppu S; Korhonen S; Simell S; Veijola R; Ilonen J; Simell O; Knip M
    Eur J Endocrinol; 2006 Oct; 155(4):633-42. PubMed ID: 16990664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The $64000 question in diabetes continues.
    Atkinson MA
    Lancet; 2000 Jul; 356(9223):4-6. PubMed ID: 10892753
    [No Abstract]   [Full Text] [Related]  

  • 13. [Latent autoimmune diabetes mellitus].
    St Martin
    Dtsch Med Wochenschr; 1999 Feb; 124(5):135. PubMed ID: 10076556
    [No Abstract]   [Full Text] [Related]  

  • 14. Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies.
    Olson JA; Olson DM; Sandborg C; Alexander S; Buckingham B
    Pediatrics; 2002 Mar; 109(3):E50. PubMed ID: 11875178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity in "type 2" and gestational diabetes mellitus.
    Fitz-Patrick D
    Endocr Pract; 2001; 7(5):407-8. PubMed ID: 11585380
    [No Abstract]   [Full Text] [Related]  

  • 16. Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.
    Hampe CS; Hall TR; Agren A; Rolandsson O
    Clin Exp Immunol; 2007 Apr; 148(1):72-8. PubMed ID: 17286757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression to type 1 diabetes is associated with a change in the immunoglobulin isotype profile of autoantibodies to glutamic acid decarboxylase (GAD65). Childhood Diabetes in Finland Study Group.
    Petersen JS; Kulmala P; Clausen JT; Knip M; Dyrberg T
    Clin Immunol; 1999 Feb; 90(2):276-81. PubMed ID: 10080840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GAD antibodies in IDDM in Thailand.
    Rattarasarn C; Aguilar-Diosdado M; Soonthornpun S; Patarakijvanich N; Jaruratanasirikul S
    Diabetes Care; 1996 Jun; 19(6):674-5. PubMed ID: 8725876
    [No Abstract]   [Full Text] [Related]  

  • 19. Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes.
    Cainelli F; Manzaroli D; Renzini C; Casali F; Concia E; Vento S
    Diabetes Care; 2000 Jul; 23(7):1021-2. PubMed ID: 10895859
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoantibodies to GAD65 and IA-2 antibodies are increased, but not tissue transglutaminase (TTG-Ab) in type 2 diabetes mellitus (T2DM) patients from South India.
    Sanjeevi CB; Balaji M; Balaji V; Seshiah V
    Ann N Y Acad Sci; 2003 Nov; 1005():387-9. PubMed ID: 14679097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.